Company page

Caredx, Inc.

CareDx, Inc. (ticker: CDNA) is a public company based in the United States, specializing in diagnostic solutions for transplant patients. With a market capitalization of approximately $1.15 billion, CareDx focuses on improving patient outcomes through innovative testing and monitoring services. The company's offerings are designed to enhance the management of transplant care and support healthcare providers in delivering optimal patient care.